Dimebon: disappointing in Alzheimer’s but might work in HD

Dimebon: disappointing in Alzheimer’s but might work in HD

Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.

Dr Jeff CarrollDecember 23, 2010

Focused drug screening leads to improved drugs to increase the rate of cellular recycling

Focused drug screening leads to improved drugs to increase the rate of cellular recycling

Advanced drug screening techniques help scientists to make drugs that increase cellular recycling in neurons.

Dr Jeff CarrollDecember 16, 2010

Does HD cause brains to develop differently?

Does HD cause brains to develop differently?

Smaller total brain volumes in male HD mutation carriers suggests brain development may be different in HD.

Dr Jeff CarrollDecember 06, 2010

Are there genetic connections between neurodegenerative diseases?

Are there genetic connections between neurodegenerative diseases?

Genetic evidence suggests connections between a polyQ disease and ALS (Lou Gehrig’s disease). Why should HD people ca

Dr Jeff CarrollDecember 01, 2010

Is Huntington’s disease twice as common as we thought?

Is Huntington’s disease twice as common as we thought?

New data suggest there may be twice as many people with HD symptoms as previously thought – and even more at risk

Dr Ed WildNovember 27, 2010

Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD

Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD

Merger of two major Huntington’s Disease observational trials creates ENROLL-HD

Dr Jeff CarrollNovember 24, 2010

Huntexil for symptoms of Huntington's disease: where are we now?

Huntexil for symptoms of Huntington's disease: where are we now?

Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex

Dr Ed WildNovember 16, 2010

Minocycline: the end of the road?

Minocycline: the end of the road?

DOMINO clinical trial result: minocycline doesn’t slow down HD and shouldn’t be studied in larger trials.

Dr Ed WildNovember 10, 2010

TRACK-HD reveals significant changes in pre-symptomatic HD mutation carriers and patients

TRACK-HD reveals significant changes in pre-symptomatic HD mutation carriers and patients

The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers

Dr Jeff CarrollNovember 01, 2010